1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies
    Meeting Abstract

    Mita, M. M.; Mita, A. C.; Chmielowski, B.; Hamilton, E. P.; Pant, S.; Waltzman, R. J.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; Kurth, I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Erinjeri, J. P.; Tan, B. R.; Reiss, K. A.; Mody, K.; Khalil, D.; Yarmohammadi, H.; Nadolski, G.; Giardina, J. D.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • 5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001
    Meeting Abstract

    Hamid, O.; Robert, C.; Daud, A.; Hodi, F. S.; Hwu, W. J.; Kefford, R.; Wolchok, J. D.; Hersey, P.; Joseph, R. W.; Weber, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multigene sequencing, copy number alteration detection, and survival with first-line PD-1 based therapy in patients with mucosal melanoma
    Meeting Abstract

    Gottesdiener, L. S.; Gormally, M.; Armenia, J.; El-Jalby, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Wolchok, J. D.; Chapman, P. B.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Assessing the value of nivolumab (NIVO) versus placebo (PBO) and ipilimumab (IPI) as adjuvant therapy for resected melanoma
    Meeting Abstract

    Freeman, M. L.; Shoushtari, A. N.; Betts, K. A.; Gupte-Singh, K.; Du, E. X.; Ritchings, C.; Rao, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases
    Meeting Abstract

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; Zhang, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Checkpoint blockade
    Book Section

    Proverbs-Singh, T. A.; Wolchok, J.; Snyder, A.
    In Cooper, L. J. N.; Mittendorf, E. A.; Moyes, J.; Prabhakaran, S. (Eds.) Immunotherapy in Translational Cancer Research (2018)

    Fulltext@MSK | Save
  • Elevated levels of BRAF(V600) mutant circulating tumor DNA and circulating hepatocyte growth factor are associated with poor prognosis in patients with metastatic melanoma
    Journal Article

    Lu, W.; Burton, L.; Larkin, J.; Chapman, P. B.; Ascierto, P. A.; Ribas, A.; Robert, C.; Sosman, J. A.; McArthur, G. A.; Chang, I.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Special considerations in immunotherapy trials
    Book Section

    Friedman, C. F.; Panageas, K. S.; Wolchok, J. D.
    In Kelly, W. K.; Halabi, S. (Eds.) Oncology Clinical Trials: Successful Design, Conduct, and Analysis. 2nd ed (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save